- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
EMR improves overall quality of healthcare
Quality of care for patients at VA facilities improved following the introduction of an integrated electronic medical record, performance measurement, and other system changes, according to the findings of a new VA study.
Quality of care for patients at VA facilities improved following the introduction of an integrated electronic medical record, performance measurement, and other system changes, according to the findings of a new VA study.
Researchers investigated the effect of sweeping changes such as the introduction of an EMR on the quality of care (Ann Intern Med 2004;141[12]:938-945). In 2003, the same team of researchers had demonstrated that U.S. adults were receiving recommended care about half of the time.
The team measured quality at 12 VA healthcare systems and 12 community systems between 1997 and 2000 using a chart-based quality instrument consisting of 348 indicators targeting 26 conditions. The VA scored significantly higher than a national sample for adjusted overall quality (67% versus 51%), chronic disease care (72% versus 59%), and preventive care (64% versus 44%).
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
